Newsletter | December 10, 2025

12.10.25 -- Unlock New Delivery Routes: The Nanoforming Revolution

Nanoforming Biologics, GLP-1s: From I.V. To Sub Q And Inhaled Delivery

Developing new delivery routes is essential for creating more effective treatments. Nanoforming enables new routes to simplify dosing, enhance patient comfort, and reduce healthcare costs.

 

Expanding Opportunities For Inhaled Drug Delivery

Explore the challenges and intricacies of effectively delivering drugs to the lung and the advantages of using nanoparticles and gentle particle processing techniques to enable delivery of sensitive drugs.

 

Enabling Subcutaneous Delivery For Improved Patient Compliance

The ability to administer high doses of biologics subcutaneously offers numerous benefits, including reduced treatment burden, improved patient convenience, and increased adherence to treatment regimens.

 

A New Look At Subcutaneous mAb Delivery Using Nanoformed Particles

A highly concentrated non-aqueous suspension of an IgG1 was developed using a patented platform. Review how the particle size of the mAb impacts the overall behavior of the drug product.

 

OPCU VIDEO FEATURE

NanoImprove The Performance Of Your Formulations

Sergie Letser, Deputy CCO, presents an overview of novel large molecule nanoforming technology capabilities. Nanoform's approach allows for the development of alternative delivery routes that otherwise wouldn’t be possible with traditional formulation approaches.

 

SOLUTIONS

Innovative Formulations And Higher Drug Loads

Unlocking superior drug performance requires advancing formulation strategies. Achieve higher drug concentrations, enhanced bioavailability, and streamlined patient dosing through next-gen particle engineering approaches.

• Request Information